To test the extent to which CC2D1A expression contributes to chemotherapy resistance in vitro, we knocked down CC2D1A expression in two different ovarian cancer cell lines, PE04 and SKOV3ip (Figure 3A). The gene discussed is CC2D1A; the disease is ovarian cancer.